Why Did Germany Reject Sildenafil OTC Switch?
Executive Summary
Sildenafil was rejected at Germany’s independent switch committee’s most recent meeting. HBW Insight examines some of the arguments for and against the switch put forward by the regulator, members of the committee and the applicant, as recorded in the recently published minutes.
You may also be interested in...
Teva UK Enters Erectile Dysfunction Category With First Ever Rx-To-OTC Switch
Teva UK's first Rx-to-OTC switch is a UK Viagra Connect sildenafil competitor under the Liberize brand. Priced around 25% lower than the market leader, Teva's new brand must also compete with Perrigo's white label and Dr Reddy's Almus branded alternatives within the country's growing erectile dysfunction category.
Viatris Welcomes ‘Healthy Competition’ For UK OTC Erectile Dysfunction Top Spot
Viatris' marketing director Rob Elliott speaks to HBW Insight about how the company is investing in flagship OTC erectile dysfunction treatment Viagra Connect to ensure the brand keeps ahead of the growing competition.
Futura’s Drug-Free Erectile Dysfunction Gel On Track For US And EU Launch
Futura Medical's latest meeting with the FDA puts the UK start-up one step closer to launching its drug-free erectile dysfunction gel MED3000 in the US in 2023, while the firm gets ready to launch in the EU next year following its recent CE-mark approval.